Apply for the start-up pitch
Call for poster abstracts
Send us your application to pitch at the AMR Conference
10 ventures will be shortlisted to pitch at the AMR Conference for a chance to win 10,000 Euros.
We are looking for translational projects, startups younger than 5 years and with less than 5 million raised. We are open in this competition to all products and technologies that can help in the fight against AMR. This includes therapeutics, platform technologies, diagnostics, vaccines, digital health tools.
Selected companies will receive one free ticket to the AMR Conference. All applicants are eligible for a discounted ticket.
The deadline for applications for the start-up pitch is 22nd January 2023.
Please click on the button below to submit your 60 seconds pitch video and a pitch deck.
The call for poster abstracts is now open
Scientists from SMEs and academic institutions are invited to submit an abstract for a poster presentation addressing the following topics:
- Traditional and non-traditional therapeutic approaches to tackle AMR in humans and animals
- Diagnostic AMR innovations for humans and animals
- Technologies enabling antimicrobial vaccine and drug development
The abstract text should not be longer than 350 words. A maximum of one picture, graph or table can be included per abstract. All abstracts will be reviewed by a scientific committee. You will be notified about the outcome of your poster application by early February 2023.
The deadline for abstract submission is 22nd January 2023.
Please send your poster abstract for review by clicking on the button below.
Please save the date for the upcoming
7th AMR Conference 2023
taking place 16-17 March at the Congress Center Basel.
About the conference
The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and specific challenges faced by the innovation ecosystem in bringing new antimicrobial treatments and diagnostics to the market.
The conference is the one-stop shop to catch up with the latest trends in the development of AMR products, by covering scientific, regulatory, financial and policy topics. Besides high-level talks, the conference is a great place to network and exchange views on innovative technologies, development paths and alternative business models with your peers. The conference also offers a partnering platform to facilitate interactions.
The 7th edition covered the whole innovation value chain, including scientific breakthrough, preclinical and clinical development, but also financial topics such as public funding for R&D, market incentive and investors’ perspective. Specific sessions were also dedicated to antimicrobials in the environment, diagnostics, antifungals, biologics and anti-tuberculosis drug combinations. There was a special focus on India and how the country is getting prepared to provide global solutions against AMR. Among other highlights were a start-up competition, hosted by the pharma-backed incubator INCATE, and a poster prize.
The AMR Conference is jointly organized by BEAM Alliance and bamconn GmbH.
The BEAM Alliance is one of the major supporting partners of the AMR Conference. Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance gathers more than 70 small and medium-sized European biotech and diagnostics companies committed to developing innovative products for fending off antibiotic-resistant pathogens. BEAM Alliance carries the voice of SMEs to support policies and incentives in antimicrobial research and development in Europe.
bamconn GmbH was established in November 2022 as a spin-off of BIOCOM AG and continues its entire event management as an independent company. It is built on more than 15 years of experience in the planning, organization and implementation of scientific events and exhibitions. The portfolio covers the entire spectrum from small workshops with 20 participants to multi-day international conferences for up to 2,000 people as well as exhibitions on the topic of bioeconomy throughout Europe. Customers for whom the bamconn team worked so far are companies, research institutions, associations and federal ministries as well as subordinate authorities and EU-funded projects.